D. Çabuk

Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study.

Clinicopathological features of breast cancer in women ≤35 years: A retrospective single-center study

Objective: Although breast cancer (BC) predominantly affects women aged ≥ 50 years, its incidence among younger women is increasing. Younger patients often present with aggressive biological features. This study aimed to compare the clinicopathological characteristics and survival outcomes between BC patients aged ≤35...